Liquid Chromatography-Tandem Mass Spectrometry Method for Determination of Homocysteine in Rat Plasma: Application to the Study of a Rat Model for Tauopathies
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
25466230
DOI
10.1093/chromsci/bmu156
PII: bmu156
Knihovny.cz E-resources
- MeSH
- Chromatography, Liquid methods MeSH
- Homocysteine blood MeSH
- Rats MeSH
- Limit of Detection MeSH
- Linear Models MeSH
- Rats, Inbred SHR MeSH
- Rats, Transgenic MeSH
- Rats, Wistar MeSH
- Reproducibility of Results MeSH
- Drug Stability MeSH
- Case-Control Studies MeSH
- Tandem Mass Spectrometry methods MeSH
- Tauopathies blood MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Homocysteine MeSH
Hyperhomocysteinemia is a common occurrence in many neurodegenerative diseases, including tauopathies. We developed and validated a simple and sensitive liquid chromatography-tandem mass spectrometry method for the analysis of homocysteine (Hcy) in rat plasma. Hcy was analyzed using ultra-performance liquid chromatography on a C8 column with detection by positive ESI tandem mass spectrometry. For optimal retention and separation, we used ion-pair reagent-heptafluorobutyric acid. The method utilizes heavy labeled internal standard and does not require any derivatization or extraction step. The procedure was validated in compliance with the European Medicines Agency guideline. The limit of detection was 0.15 µmol/L and the limit of quantification was 0.5 µmol/L. The method showed excellent linearity with regression coefficients higher than 0.99. The accuracy was in the range of 93-98%. The inter-day precision (n = 5 days), expressed as % relative standard deviation, was in the range 3-8%. Using this method, we analyzed plasma samples from two transgenic lines of the rat model for tauopathies.
References provided by Crossref.org